Catalina Capital Group, LLC Compass Therapeutics, Inc. Transaction History
Catalina Capital Group, LLC
- $304 Billion
- Q4 2024
A detailed history of Catalina Capital Group, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Catalina Capital Group, LLC holds 48,964 shares of CMPX stock, worth $156,684. This represents 0.02% of its overall portfolio holdings.
Number of Shares
48,964Holding current value
$156,684% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CMPX
# of Institutions
82Shares Held
92.4MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$71.6 Million0.97% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$35.6 Million0.04% of portfolio
-
Blackstone Inc New York, NY10MShares$32.1 Million0.09% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$21.2 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA5.64MShares$18.1 Million1.62% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $324M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...